The role of sympathic autonomous system in arterial hypertension (AH) pathogenesis is described. Predictive value of left ventricular hypertrophy (LVH) in cardiovascular event prognosis is emphasized. The results of clinical trials assessing imidazoline receptor agonists’ influence on LVH during AH management are discussed
